--- description: Find out why Kiran Musunuru and Rebecca Ahrens-Nicklas is on the TIME100 Health 2026 list. title: TIME100 Health: Kiran Musunuru and Rebecca Ahrens-Nicklas image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2bdfe7d0cb54d38b/6998ce4a1f67095e7ff573db/T100-Health-2026-Ahrens-Nicklas-Musunuru.png?branch=production&width=3840&quality=75&auto=webp&crop=16:9 --- Feb 11, 2026 # Kiran Musunuru and Rebecca Ahrens-Nicklas ## Video: How scientists used the first-ever custom gene therapy to treat a baby | TIM100 HEALTH [Watch (HLS stream): How scientists used the first-ever custom gene therapy to treat a baby | TIM100 HEALTH](https://cdn.jwplayer.com/manifests/15t7itzY.m3u8) (1:23)  _Published 2026-02-11. Find out why they're on the TIME100 Health 2026 list._ Saving a baby from genetic disease by [Alice Park](/author/alice-park/) ## Alice Park Update your preferences in [Account Settings](/account/preferences/) Close Senior Correspondent  Courtesy of Penn Medicine; Courtesy of Children's Hospital of Philadelphia As a doctor who treats babies with rare genetic diseases, Dr. Rebecca Ahrens-Nicklas, director of the Gene Therapy for Inherited Metabolic Disorders Frontier Program at Children’s Hospital of Philadelphia, is accustomed to sharing difficult news with families. For many of the babies, the only treatment available is palliative care. To change that, in 2023, Ahrens-Nicklas partnered with Dr. Kiran Musunuru, director of the Genetic and Epigenetic Origins of Disease Program at the University of Pennsylvania Perelman School of Medicine, who has been researching ways to use the CRISPR gene-editing technique to treat such conditions. Their goal was to use the new method to correct the mutations that Ahrens-Nicklas’ patients were born with, so babies weren’t as severely affected by their conditions. But the timing was critical, since often the longer babies live with the effects of their mutations, the more severe their symptoms become. When KJ Muldoon was born in August 2024 with mutations that led to a missing enzyme he needed to process proteins properly, Ahrens-Nicklas knew she had to act fast. Most with his condition need a liver transplant—but they have to live long enough to be able to handle that major surgery. Without the enzyme, KJ’s body built up dangerous levels of ammonia, and the longer this toxic process continued, the more it would affect his development. There was no CRISPR-based treatment for his mutation yet, so Ahrens-Nicklas and Musunuru worked with the team of CRISPR co-discoverer Jennifer Doudna to create a world-first customized gene therapy for KJ. Trying a new therapy on an infant is risky, and Ahrens-Nicklas rallied the team to push KJ’s therapy through the normal testing process, which starts in animals, to ensure it was safe and likely to help him. At just 6 months old, in early 2025, KJ received the first personalized CRISPR therapy, designed to address his specific mutation, given via three infusions. KJ has now celebrated his first birthday, and the treatment seems to have spared him from the severe effects of his disease, says Ahrens-Nicklas. The team will continue to monitor his progress. Beyond KJ’s success, his treatment has spurred Ahrens-Nicklas and Musunuru to work on developing custom therapies for other patients. And Doudna (who received the Nobel Prize for her CRISPR work) is also focused on expanding the applications of her groundbreaking discovery. Last year, she partnered with Priscilla Chan Zuckerberg of the Chan Zuckerberg Initiative to create a new center, housed at the University of California, San Francisco, and the University of California, Berkeley, to bring bespoke gene therapies to more patients like KJ. “I don’t think it’s exaggerating to say that this is the future of medicine,” says Musunuru. [_Click here to buy your copy of this issue_](https://magazineshop.us/health26 "undefined") TIME100 Health: Kiran Musunuru and Rebecca Ahrens-Nicklas ```json [{"@context":"https://schema.org","@type":"Article","@id":"https://time.com/collections/time100-health-2026/7362523/kiran-musunuru-and-rebecca-ahrens-nicklas/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/collections/time100-health-2026/7362523/kiran-musunuru-and-rebecca-ahrens-nicklas/"},"headline":"Kiran Musunuru and Rebecca Ahrens-Nicklas","datePublished":"2026-02-11T13:01:16.000Z","dateModified":"2026-03-03T01:06:43.593Z","description":"Find out why they're on the TIME100 Health 2026 list.","url":"https://time.com/collections/time100-health-2026/7362523/kiran-musunuru-and-rebecca-ahrens-nicklas/","keywords":["TIME100 Health 2026","list","franchise","Magazine","Special Project","sponsorshipblock","Accolades"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2bdfe7d0cb54d38b/6998ce4a1f67095e7ff573db/T100-Health-2026-Ahrens-Nicklas-Musunuru.png?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"creator":"Alice Park","articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2bdfe7d0cb54d38b/6998ce4a1f67095e7ff573db/T100-Health-2026-Ahrens-Nicklas-Musunuru.png?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/time100-health-2026/","name":"TIME100 Health 2026"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/collections/time100-health-2026/7362523/kiran-musunuru-and-rebecca-ahrens-nicklas/","name":"Kiran Musunuru and Rebecca Ahrens-Nicklas"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"How scientists used the first-ever custom gene therapy to treat a baby | TIM100 HEALTH","description":"Find out why they're on the TIME100 Health 2026 list.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/15t7itzY/poster.jpg?width=720","uploadDate":"2026-02-11T12:30:00.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/15t7itzY.m3u8","embedUrl":"https://time.com/collections/time100-health-2026/7362523/kiran-musunuru-and-rebecca-ahrens-nicklas/","duration":"PT1M23S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/collections/time100-health-2026/7362523/kiran-musunuru-and-rebecca-ahrens-nicklas/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```